Henderson Group »

Catalyst Pharmaceutical Partners shares owned by Henderson Group

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Henderson Group from 13F filings

Historical chart of Henderson Group investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by Henderson Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by Henderson Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $19M 1.1M 16.80
2023-09-30 $4.8M 408k 11.68
2023-06-30 $4.1M 307k 13.44
2023-03-31 $719k 43k 16.58
2022-12-31 $372k 20k 18.60
2022-09-30 $263k 20k 13.11
2022-03-31 $1.0M 124k 8.30
2021-12-31 $1.1M 158k 6.77
2021-09-30 $759k 143k 5.30
2021-06-30 $978k 170k 5.75

More positions owned by Henderson Group

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Mastercard Incorporated Cl A (MA)
UnitedHealth (UNH)
Eli Lilly & Co. (LLY)
Workday Cl A (WDAY)
Lam Research Corporation (LRCX)
Booking Holdings (BKNG)
Adobe Systems Incorporated (ADBE)
Deere & Company (DE)
Abbvie (ABBV)

View all positions for Henderson Group

Top funds holding Catalyst Pharmaceutical Partners

BlackRock
Deerfield Management Company
Vanguard Group
Dimensional Fund Advisors
Geode Capital Management
Royce & Associates
Robeco Investment Management
Northern Trust
Jacobs Levy Equity Management
Opaleye Management
T. Rowe Price Associates
Henderson Group
Charles Schwab Investment Management
Goldman Sachs Group
LSV Asset Management

View all funds holding Catalyst Pharmaceutical Partners